Beech Hill Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,717
Closed -$273K 76
2019
Q3
$273K Buy
6,717
+1,600
+31% +$67.8K 0.15% 71
2019
Q2
$220K Buy
+5,117
New +$197K 0.12% 72
2018
Q2
Sell
-8,117
Closed -$222K 73
2018
Q1
$222K Buy
+8,117
New +$221K 0.12% 69
2017
Q4
Sell
-12,117
Closed -$353K 86
2017
Q3
$353K Buy
+12,117
New +$335K 0.19% 62
2017
Q1
Sell
-22,617
Closed -$489K 82
2016
Q4
$489K Sell
22,617
-2,000
-8% -$43.6K 0.29% 52
2016
Q3
$586K Buy
24,617
+7,000
+40% +$167K 0.36% 43
2016
Q2
$412K Sell
17,617
-3,500
-17% -$75.7K 0.28% 51
2016
Q1
$397K Hold
21,117
0.31% 44
2015
Q4
$389K Buy
21,117
+10,000
+90% +$179K 0.25% 62
2015
Q3
$182K Hold
11,117
0.12% 85
2015
Q2
$197K Buy
+11,117
New +$199K 0.1% 96

Other funds holding BSX

Beech Hill Advisors's BSX Position: Q4 2019 in Review

Beech Hill Advisors sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 6,717 shares — an estimated $273K sold.

Beech Hill Advisors first reported a position in BSX in Q2 2015 and held it in 11 quarters. The position peaked at $586K in Q3 2016. 854 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

  • Beech Hill Advisors reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
  • Beech Hill Advisors sold 6,717 Boston Scientific shares in Q4 2019, an estimated $273K.
  • Beech Hill Advisors first reported a position in Boston Scientific in Q2 2015 and held it in 11 quarters.
  • Beech Hill Advisors's Boston Scientific position peaked at $586K in Q3 2016.
  • 854 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Beech Hill Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.